The peer review history for this article is available at https://publons.com/publon/10.1111/dom.14934. Data available on request due to privacy/ethical restrictions Appendix S1. Supporting Information. Table S1. Results of the correlation analysis. %CGM, proportion of time when the continuous glucose monitoring worked; TIR, time in range; GRI, glycaemia risk index; SG, sensor glucose; %CV, glycaemic variability; %HCL, proportion of time when the hybrid closed loop was enabled; TDD, total daily dose. Level of significance: * P ≤ 0.001; # P ≤ 0.01; ° P < 0.05 Table S2. Results of the forward stepwise multivariate regression analysis. TIR, time in range; %CGM, proportion of time when the continuous glucose monitoring worked; %HCL, proportion of time when the hybrid closed loop was enabled; TDD, total daily dose; GRI, glycaemia risk index. Figure S1. The upper part displays the boxplot HbA1c during the 24-month study. The lower part displays the percentage of patients with time spent with sensor glucose below 70 mg/dL (TBR) < 4%, within 70 and 180 mg/dL (TIR) > 70%, and above 180 mg/dL (TAR) < 25% at each timepoint of the study. Figure S2. Rate of basal and premeal insulin during the study. The TDD was 0.91 ± 0.26 IU/kg/d at baseline, 0.90 ± 0.24 IU/kg/d at 6 months, 0.90 ± 0.20 IU/kg/d at 12 months, 0.90 ± 0.22 IU/kg/d at 18 months, and 0.90 ± 0.22 IU/kg/d at 24 months. No statistical differences were found. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.